Namrata Bhatnagar

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.

Bandana Sharma, Wenchao Wang, Nathanael S Gray, 2012, Cancer cell.

Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells

Qunshu Zhang, B. Guo, M. Tang, 2010, Cell Death and Disease.

Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma

K. Ross, K. Stegmaier, N. Gray, 2014, Oncotarget.

ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT

N. Gray, N. Cheung, R. George, 2015, Oncogene.

3,3′-Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention through Down-Regulation of Survivin

Xia Li, S. Garrett, X. Zhou, 2009, Cancer Prevention Research.